These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2871105)

  • 1. NK cells suppress the generation of Lyt-2+ cytolytic T cells by suppressing or eliminating dendritic cells.
    Gilbertson SM; Shah PD; Rowley DA
    J Immunol; 1986 May; 136(10):3567-71. PubMed ID: 2871105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.
    Koo GC; Manyak CL
    J Immunol; 1986 Sep; 137(6):1751-6. PubMed ID: 2427580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA; Natuk RJ; Welsh RM
    J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.
    Hefeneider SH; Conlon PJ; Henney CS; Gillis S
    J Immunol; 1983 Jan; 130(1):222-7. PubMed ID: 6600178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of cell-mediated lymphocytotoxicity against minor histocompatibility antigens mediated by Lyt-1+Lyt-2+ T cells of stimulator-strain origin.
    Rammensee HG; Nagy ZA; Klein J
    Eur J Immunol; 1982 Nov; 12(11):930-4. PubMed ID: 6217978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.
    Ballas ZK; Rasmussen W; van Otegham JK
    J Immunol; 1987 Mar; 138(5):1647-52. PubMed ID: 2879870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity.
    Budd RC; Cerottini JC; MacDonald HR
    J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population.
    Ernst PB; Clark DA; Rosenthal KL; Befus AD; Bienenstock J
    J Immunol; 1986 Mar; 136(6):2121-6. PubMed ID: 2936822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor phenotype of lymphokine-activated killer cells in the mouse.
    Salup RR; Mathieson BJ; Wiltrout RH
    J Immunol; 1987 Jun; 138(11):3635-9. PubMed ID: 3108370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific Lyt-2+ cytolytic T lymphocytes from mice infected with the intracellular bacterium Listeria monocytogenes.
    De Libero G; Kaufmann SH
    J Immunol; 1986 Oct; 137(8):2688-94. PubMed ID: 3489772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of antitumor effector cells that are effective in vivo from spleen cells of tumor-bearing mice through the use of Dolichos biflorus lectin.
    Okada T; Ezawa K; Imai Y; Osawa T
    Cancer Res; 1986 Nov; 46(11):5611-7. PubMed ID: 3093067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-induced cytotoxicity: characterization of effectors, precursors, and regulatory ancillary cells.
    Ting CC; Yang SS; Hargrove ME
    Cancer Res; 1986 Feb; 46(2):513-8. PubMed ID: 3079663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes.
    Brooks CG; Holscher M
    J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression.
    Hurwitz JL; McAndrew EC; Doherty PC
    J Immunol; 1986 Sep; 137(6):1757-63. PubMed ID: 2875109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells and tumor immunity: 1985.
    Herberman RB
    Year Immunol; 1986; 2():254-60. PubMed ID: 3033946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.